WG3
Methodology for the development and validation of new stent designs

The WG3 will be in charge of developing the Methodology and validation protocols of future urinary tract stents.

Milestones.

The production of a validation protocol (design, control, guidance for medical devices) (M16).
Tests via in-silico simulation, 3D-printing, Exvivo-Invivo assessment and Preclinical testing considerations (M24).

D3. Report on Comprehensive Methodology and Validation protocol on new stent designs, including scientific publications related to the WG3 of the Action (M24), with TS and STSM related to the WG3 of the Action (M24).

Leader: Sotir Stavridis
Vice-Leader: Wolfgang Kram

Stay informed about ENIUS Action and receive the latest news in your email

Subscribe our newsletter

ENIUS

COST is supported by the EU
Framework Programme Horizon 2020.

Contact

COST Association
Avenue Lousie 149 | 1050 Brussels, Belgium
info@enius.org

Tel: +32 (0)2 533 3800 | Fax: Fax: +32 (0)2 533 3890

Email us

COST Action

European Network of Multidisciplinary Research to Improve the Urinary Stents (ENIUS)